nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamibarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0777	0.0777	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0745	0.0745	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.0308	0.0308	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.0295	0.0295	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.0255	0.0255	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.0249	0.0249	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.0245	0.0245	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.0238	0.0238	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—PPARG—malignant glioma	0.0227	0.0227	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.0219	0.0219	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—PPARG—malignant glioma	0.0218	0.0218	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.021	0.021	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.018	0.018	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.0172	0.0172	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.0166	0.0166	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.0164	0.0164	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.0159	0.0159	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.0157	0.0157	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.0157	0.0157	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.0151	0.0151	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.014	0.014	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.0135	0.0135	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.0128	0.0128	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.0123	0.0123	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—NCOR1—malignant glioma	0.0114	0.0114	CbGpPWpGaD
Tamibarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.0109	0.0109	CbGpPWpGaD
Tamibarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.0104	0.0104	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00998	0.00998	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—HIF1A—malignant glioma	0.00959	0.00959	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00957	0.00957	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00928	0.00928	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.0092	0.0092	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00889	0.00889	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00882	0.00882	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00835	0.00835	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—PPARG—malignant glioma	0.00815	0.00815	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00801	0.00801	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00746	0.00746	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00716	0.00716	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00669	0.00669	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00648	0.00648	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00641	0.00641	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.0064	0.0064	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00621	0.00621	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00614	0.00614	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00593	0.00593	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00568	0.00568	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00545	0.00545	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00532	0.00532	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00523	0.00523	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00518	0.00518	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.0051	0.0051	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NOTCH2—malignant glioma	0.0051	0.0051	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00508	0.00508	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00503	0.00503	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—STAT3—malignant glioma	0.005	0.005	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00496	0.00496	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00492	0.00492	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00489	0.00489	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00487	0.00487	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00482	0.00482	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00471	0.00471	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00457	0.00457	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00456	0.00456	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00438	0.00438	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00438	0.00438	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NCOR1—malignant glioma	0.00433	0.00433	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—TNF—malignant glioma	0.00433	0.00433	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00429	0.00429	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NCOR1—malignant glioma	0.00415	0.00415	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00411	0.00411	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—DNMT3B—malignant glioma	0.00405	0.00405	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—HIST1H3B—malignant glioma	0.00393	0.00393	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—DNMT3B—malignant glioma	0.00388	0.00388	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00387	0.00387	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—HIST1H3B—malignant glioma	0.00377	0.00377	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00371	0.00371	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00356	0.00356	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00349	0.00349	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00342	0.00342	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00334	0.00334	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00332	0.00332	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00329	0.00329	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00329	0.00329	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00318	0.00318	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00316	0.00316	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00315	0.00315	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—PPARG—malignant glioma	0.00311	0.00311	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—H3F3A—malignant glioma	0.00304	0.00304	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.00303	0.00303	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—PPARG—malignant glioma	0.00298	0.00298	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00293	0.00293	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—H3F3A—malignant glioma	0.00291	0.00291	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.0029	0.0029	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NOTCH3—malignant glioma	0.00285	0.00285	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00281	0.00281	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NOTCH3—malignant glioma	0.00274	0.00274	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NOTCH2—malignant glioma	0.00256	0.00256	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00247	0.00247	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NOTCH2—malignant glioma	0.00245	0.00245	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00237	0.00237	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—CDKN2B—malignant glioma	0.0022	0.0022	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—CDKN2B—malignant glioma	0.00211	0.00211	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NCOR1—malignant glioma	0.00209	0.00209	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NCOR1—malignant glioma	0.002	0.002	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—MYC—malignant glioma	0.00177	0.00177	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—MYC—malignant glioma	0.0017	0.0017	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NOTCH1—malignant glioma	0.00158	0.00158	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NOTCH1—malignant glioma	0.00152	0.00152	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—PPARG—malignant glioma	0.0015	0.0015	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—PPARG—malignant glioma	0.00143	0.00143	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—MYC—malignant glioma	0.000852	0.000852	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—MYC—malignant glioma	0.000817	0.000817	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—AKT1—malignant glioma	0.000591	0.000591	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—AKT1—malignant glioma	0.000567	0.000567	CbGpPWpGaD
